SCHEMBL9769832

SCHEMBL9769832

O=C(O)C(=C(c1ccc(F)cc1)c1ccc(F)cc1)n1cnnn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.45
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 3/20 0.38
NPC1 O15118 1/20 0.38
KCNJ1 P48048 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
BCL2L1 Q07817 1/20 0.36
BAD Q92934 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
LTA4H P09960 1/20 0.34
F2 P00734 1/20 0.34
PLAU P00749 1/20 0.34
KLKB1 P03952 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769860 0.80 HMGCR (0.42) HMGCRALDH1A1RAB9ANPC1CES2
SCHEMBL9769859 0.76 HMGCR (0.53) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769845 0.74 HMGCR (0.43) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769877 0.73 HMGCR (0.42) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769903 0.71 HMGCR (0.42) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769899 0.71 HMGCR (0.54) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769780 0.70 HMGCR (0.39) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL9769825 0.68 HMGCR (0.39) HMGCRALDH1A1RAB9ANPC1KCNJ1
SCHEMBL4502875 0.64
SCHEMBL23344842 0.62 BCL2L1 (0.74) ALDH1A1RAB9ANPC1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5070206-A INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE; ANTICHOLESTEROL, ANTILIPEMIC BRISTOL-MYERS COMPANY (US) 1991-12-03 US disclosed
US-5010205-A Antihypercholesterolemic tetrazol-1-yl intermediates BRISTOL-MYERS COMPANY (US) 1991-04-23 US disclosed
EP-0355820-A1 Antihypercholesterolemic tetrazol-1-yl compounds Bristol-Myers Squibb Company (US) 1990-02-28 EP disclosed
US-4870187-A ANTILIPEMIC, ATHEROSCLEROSIS BRISTOL-MYERS COMPANY (US) 1989-09-26 US disclosed